Generation of a Potential Prognostic Matrix for Papillary Thyroid Cancer that Assesses Age, Tumor Size, Transforming Growth Factor-β, and BRAFV600E Mutation

Publisher： Karger

E-ISSN： 2296-5262|40|10|586-592

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.40, Iss.10, 2017-09, pp. : 586-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Time to re‐consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1001-1011

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synchronous and metachronous thyroid cancer in relation to Langerhans cell histiocytosis; involvement of V600E BRAF‐mutation?

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 173-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine‐needle aspiration specimens of papillary thyroid carcinoma

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 10, 2015-10 ,pp. : 786-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extended Antitumor Responseof a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-05 ,pp. : 343-348

Karger

Access to resources Recommend Favorite

Quality Control and Telemedicine for BRAF V600E Mutations in Papillary Thyroid Carcinomas: Image Analysis and Classification and Regression Trees

By  

International Journal of Reliable and Quality E-Healthcare (IJRQEH), Vol. 4, Iss. 2, 2015-04 ,pp. : 12-30

IGI Global_journal

Access to resources Recommend Favorite